Enlarge / US President Joe Biden speaks at the Detroit Auto Show, in Detroit on September 14, 2022. reader comments 263 with 134 posters participating Share this story “The pandemic is over,” President Joe Biden said matter-of-factly in a 60 Minutes interview that aired Sunday night. The impromptu comment immediately drew headlines, as well as ..
Enlarge / An Army veteran waits the recommended 15 minutes to see if he will have any adverse reactions after receiving his second COVID-19 booster shot at Edward Hines Jr. VA Hospital on April 1, 2022, in Hines, Illinois. reader comments 110 with 49 posters participating Share this story As expected, the Food and Drug ..
reader comments 65 with 52 posters participating Share this story The swift rise of omicron subvariant BA.5—with its increased immune-evading abilities and demonstrable growth advantage—has federal officials on edge. In a flurry of activity late Monday and early Tuesday, officials doubled down on pandemic measures, renewed calls for vigilance, and are considering expanding eligibility of ..
Enlarge / A sign for a vaccine site stands in Staten Island on November 29, 2021, in New York City. reader comments 157 with 89 posters participating Share this story With pandemic funding running out, the Biden administration is repurposing $10 billion to buy next-generation COVID-19 booster doses for the fall, as well as treatments, ..
Enlarge / A vial of the current Moderna COVID-19 vaccine. reader comments 58 with 39 posters participating Share this story A combination COVID-19 booster dose that targets the ancestral strain of SARS-CoV-2 and the initial omicron variant, BA.1, appears to outperform the current booster against both of those versions of the virus, Moderna reported Wednesday. ..
Enlarge / A person holds a positive SARS-CoV-2 rapid test on February 17, 2022 in Berlin, Germany. reader comments 97 with 57 posters participating Share this story Omicron subvariant BA.2.12.1 has overtaken BA.2 as the dominant version of the pandemic coronavirus in the US, now accounting for an estimated 59 percent of cases nationwide. But ..
Enlarge / The Comirnaty (Pfizer/BioNTech) and Moderna COVID-19 vaccines. reader comments 67 with 50 posters participating Share this story Covid-19 Coverage View more stories People ages 60 and older who were initially vaccinated with two Pfizer-BioNTech COVID-19 vaccine doses were better protected from the omicron coronavirus variant after being boosted with a Moderna vaccine rather ..
Enlarge / A tray of prepared syringes for booster vaccinations with Moderna’s vaccine. reader comments 62 with 42 posters participating Share this story Covid-19 Coverage View more stories A COVID-19 booster targeting two versions of the coronavirus in one shot offered stronger and broader protection than the current booster, which targets only one version, according ..
Enlarge / A vial of the current Moderna COVID-19 vaccine. reader comments 39 with 28 posters participating Share this story Covid-19 Coverage View more stories Mild or not, more SARS-CoV-2 variants are inevitable. To avoid any blips in our pandemic endgame, researchers at the National Institutes of Health on Thursday announced the start of a ..
Enlarge / The US Food and Drug Administration in Silver Spring, Maryland. reader comments 60 with 43 posters participating Share this story Covid-19 Coverage View more stories Vaccine-makers Moderna and Pfizer have now both submitted requests for the US Food and Drug Administration to authorize fourth doses—second boosters—of their COVID-19 vaccines. Pfizer, along with vaccine ..